TP63 and non-small cell lung carcinoma: Some previous studies showed that genetic variants in TP63 were associated with an increased risk of lung adenocarcinoma,26, 27, 28 but genomic amplification of p63 is paradoxically associated with prolonged survival in NSCLC.29